About Erasca (ERAS)
Erasca, Inc is a clinical-stage precision oncology company. The Company is focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The Company is engaged in oncology and RAS targeting to cr... Read more
- USD1.26
- USD1.28
- USD1.21
- USD3.45
- 7.80%
- --
- 2.81M
- 1.40M
- 448M
- 1.01
- -43.40%
Stock News
5 hours ago
Fidelity Total Bond ETF Q1 2025 Commentary
SeekingAlpha
6 hours ago
Hartford Dividend And Growth Fund Q1 2025 Commentary
SeekingAlpha
6 hours ago
Inotiv, Inc. (NOTV) Q2 2025 Earnings Call Transcript
SeekingAlpha
yesterday
Dutch Bros’ earnings results show not everything is terrible for coffee chains
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
